会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • PACKAGE FOR SEGREGATING AND MIXING SUBSTANCES
    • 分离和混合物质的包装
    • WO2005044692A1
    • 2005-05-19
    • PCT/US2004/013181
    • 2004-04-28
    • KIMBERLY-CLARK WORLDWIDE, INC.SCHMIDT, Paul, R.MURPH, Nefetari, B.BRUNNER, Michael, S.LINDON, Jack
    • SCHMIDT, Paul, R.MURPH, Nefetari, B.BRUNNER, Michael, S.LINDON, Jack
    • B65D81/32
    • B65D81/3266
    • The present invention relates to a package that includes an enclosure (11) having a first substance (14) and a second substance (15) within the enclosure. The package further includes a plastic zipper (18) which segregates the first substance from the second substance within the enclosure such that opening the plastic zipper (18) allows the first substance and the second substance to be mixed together inside the enclosure. In another aspect, the package includes a gas-permeable enclosure and first and second solid substances stored within the enclosure. A mechanism, such as a plastic zipper, segregates the first and second solid substances. Opening the mechanism allows a user to mix the first and second solid substances inside the enclosure to produce a gas. The package permits the gas that is produced to permeate through the gas-permeable enclosure for distribution throughout an area.
    • 本发明涉及一种包装盒,其包括在外壳内具有第一物质(14)和第二物质(15)的外壳(11)。 该包装还包括塑料拉链(18),该塑料拉链将第一物质与外壳内的第二物质隔开,使得打开塑料拉链(18)允许第一物质和第二物质在外壳内混合在一起。 在另一方面,包装包括气体可渗透的外壳和存储在外壳内的第一和第二固体物质。 诸如塑料拉链的机构分离第一和第二固体物质。 打开机构允许用户将第一和第二固体物质混合在外壳内以产生气体。 该包装允许产生的气体渗透通过气体可渗透的外壳以分布在整个区域中。
    • 8. 发明申请
    • CONTROLLED RELEASE COMPOSITIONS OF ESTRADIOL METABOLITES
    • ESTRADIOL代谢物的控制释放组成
    • WO2003092585A2
    • 2003-11-13
    • PCT/US2003/012727
    • 2003-04-25
    • PR PHARMACEUTICALS, INC.ALLISON, Dean, S.SCHMIDT, Paul, G.HUDNUT, Paul, S.
    • ALLISON, Dean, S.SCHMIDT, Paul, G.HUDNUT, Paul, S.
    • A61K
    • A61K9/5153A61K9/145A61K9/1647A61K9/7038A61K31/56A61K31/565A61K47/10
    • The present invention provides improved sustained release formulations of estradiol metabolites, including 2-hydroxyestradiol, 2-methoxyestradiol, 4-hydroxyestradiol and 4-methoxyestradiol, useful for therapeutic treatments. The invention also provides methods of producing sustained release forms of estradiol metabolites. The compositions of the present invention include microparticles, nanoparticles, patches, crystals, gels, rods, stints, pellets, discs, lozenges, wafers, capsules, films, microcapsules, nanocapsules, hydrogels, liposomes, implants and vaginal rings. Compositions also include formulations for transdermal and intravenous delivery of estradiol metabolites. The present invention provides numerous improvements over previous forms of estradiol metabolites, such advantages including the sustained release of normally short half-life compounds to maintain therapeutic blood levels.
    • 本发明提供可用于治疗性治疗的改进的雌二醇代谢物的缓释制剂,包括2-羟基雌二醇,2-甲氧基雌二醇,4-羟基雌二醇和4-甲氧基雌二醇。 本发明还提供了产生雌二醇代谢物的持续释放形式的方法。 本发明的组合物包括微粒,纳米颗粒,贴剂,晶体,凝胶,棒,钉,丸,盘,锭剂,晶片,胶囊,膜,微胶囊,纳米胶囊,水凝胶,脂质体,植入物和阴道环。 组合物还包括用于经皮和静脉内递送雌二醇代谢物的制剂。 本发明提供了与先前形式的雌二醇代谢物相比的许多改进,包括持续释放通常短的半衰期化合物以维持治疗血液水平的优点。